ENTA·29251M106·US·equity·Healthcare - Biotechnology-13D/G
ENTA (ENANTA PHARMACEUTICALS INC) is held by 74 institutional investors as of Q1 2026. Largest holders: JANUS HENDERSON GROUP PLC ($47.7M), BlackRock, Inc. ($39.2M), FARALLON CAPITAL MANAGEMENT LLC ($36.3M). Net institutional sentiment: Mixed.
See how ENTA's score breaks down across 4 SEC sources
Showing 1-20 of 84
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer